ADVANCED-PLATELET RICH FIBRIN – A NEW ACQUISITION IN JAW OSTEONECROSIS TREATMENT
Introduction. Osteonecrosis of the jaw represents an adverse effect of a classes of drugs with both anti-osteoclastic properties and antiangiogenic properties [1], the causal association of this type of medication with osteonecrosis of the jaw was established more than a decade ago. Aim of the study...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Romanian Society of Oral Rehabilitation
2018-01-01
|
| Series: | Romanian Journal of Oral Rehabilitation |
| Subjects: | |
| Online Access: | http://www.rjor.ro/advanced-platelet-rich-fibrin-a-new-acquisition-in-jaw-osteonecrosis-treatment/?lang=ro |